Koss-Olinger Consulting’s Boston Scientific BSX Stock Holding History

Koss-Olinger Consulting’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,087	Closed	-$294K	–	268
2025 Q4	$294K	Sell	3,087 -1,874	-38%	-$184K	0.02%	227
2025 Q3	$533K	Hold	4,961	–	–	0.04%	195
2025 Q2	$533K	Buy	4,961 +15	+0.3%	+$1.52K	0.04%	196
2025 Q1	$499K	Buy	+4,946	New	+$498K	0.04%	200
2024 Q4	–	Sell	-4,946	Closed	-$414K	–	202
2024 Q3	$414K	Hold	4,946	–	–	0.04%	184
2024 Q2	$381K	Buy	+4,946	New	+$362K	0.04%	179
2024 Q1	–	Sell	-5,252	Closed	-$304K	–	86
2023 Q4	$304K	Sell	5,252 -74	-1%	-$3.95K	0.03%	237
2023 Q3	$281K	Buy	5,326 +4	+0.1%	+$210	0.04%	197
2023 Q2	$288K	Hold	5,322	–	–	0.03%	190
2023 Q1	$266K	Buy	5,322 +191	+4%	+$9K	0.03%	189
2022 Q4	$237K	Buy	+5,131	New	+$222K	0.03%	185
2021 Q4	–	Sell	-6,731	Closed	-$292K	–	221
2021 Q3	$292K	Buy	+6,731	New	+$298K	0.05%	175

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Koss-Olinger Consulting's BSX Position: Q1 2026 in Review

Koss-Olinger Consulting sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 3,087 shares — an estimated $294K sold.

Koss-Olinger Consulting first reported a position in BSX in Q3 2021 and held it in 12 quarters. The position peaked at $533K in Q3 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Koss-Olinger Consulting reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Koss-Olinger Consulting sold 3,087 Boston Scientific shares in Q1 2026, an estimated $294K.
Koss-Olinger Consulting first reported a position in Boston Scientific in Q3 2021 and held it in 12 quarters.
Koss-Olinger Consulting's Boston Scientific position peaked at $533K in Q3 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Koss-Olinger Consulting's 13F filing for Q1 2026, filed 7 May 2026.